Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer
暂无分享,去创建一个
Ming Yao | Jing Li | Xianghuo He | M. Yao | Xiao-Min Wang | Ming-Xia Yan | Lei Liu | De-Shui Jia | Qin Geng | He-Chun Lin | Xiang-Huo He | Jin-Jun Li | M. Yan | He-chun Lin | Jing Li | Lei Liu | Q. Geng | Degong Jia | Xiao-min Wang | Jin-jun Li | Ming-xia Yan | Qin Geng
[1] Shanthi M. Colaco,et al. Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: hypothesis for a paraneoplastic phenomenon. , 2011, European journal of dermatology : EJD.
[2] F. Tsai,et al. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. , 2009, Lung cancer.
[3] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[4] Lei Liu,et al. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion , 2010, BMC Cancer.
[5] R. Nagle,et al. Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. , 2004, Neoplasia.
[6] Alexander Nyström,et al. Laminin isoforms in development and disease , 2007, Journal of Molecular Medicine.
[7] C. DiPersio,et al. Integrin α3β1 as a breast cancer target , 2011, Expert opinion on therapeutic targets.
[8] Albert-László Barabási,et al. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans , 2007, Nature Biotechnology.
[9] R. Eils,et al. Gene network dynamics controlling keratinocyte migration , 2008, Molecular systems biology.
[10] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[11] Hao Wang,et al. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo , 2010, Cancer Immunology, Immunotherapy.
[12] Ardeshir Bayat,et al. Degenerate Wave and Capacitive Coupling Increase Human MSC Invasion and Proliferation While Reducing Cytotoxicity in an In Vitro Wound Healing Model , 2011, PloS one.
[13] 蔡輔仁,et al. Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-kB-dependent pathway , 2009 .
[14] V. Quaranta,et al. Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression* , 2008, Journal of Biological Chemistry.
[15] Guofeng Zhang,et al. Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells , 2011, Virology Journal.
[16] D. Lin,et al. Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[17] J. Rogers,et al. Coping with cold: An integrative, multitissue analysis of the transcriptome of a poikilothermic vertebrate. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Kerbel,et al. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. , 2008, Cancer research.
[19] D. Tarin. Clinical and Biological Implications of the Tumor Microenvironment , 2012, Cancer Microenvironment.
[20] Hiroyuki Yamamoto,et al. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer. , 2011, International journal of oncology.
[21] Guoxin Zhang,et al. Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines , 2011, PloS one.
[22] D. Nguyen. Tracing the origins of metastasis , 2011, The Journal of pathology.
[23] P. simon-Assmann,et al. Role of laminins in physiological and pathological angiogenesis. , 2011, The International journal of developmental biology.
[24] Takako Sasaki,et al. Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors. , 2011, Experimental cell research.
[25] Susanna M Cramb,et al. The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] I. Han,et al. Keratinocyte-derived Laminin-332 Promotes Adhesion and Migration in Melanocytes and Melanoma* , 2011, The Journal of Biological Chemistry.
[27] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[28] Y. Ohe,et al. Abrogation of the interaction between osteopontin and αvβ3 integrin reduces tumor growth of human lung cancer cells in mice , 2007 .
[29] A. Jemal,et al. Global Cancer Statistics , 2011 .
[30] K. Syrigos,et al. Cell Adhesion Molecules: Role and Clinical Significance in Cancer , 2009, Cancer investigation.
[31] M. El-Tanani. Role of osteopontin in cellular signaling and metastatic phenotype. , 2008, Frontiers in bioscience : a journal and virtual library.
[32] Susumu Goto,et al. The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..
[33] T. Okada,et al. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1 , 2008, Clinical & Experimental Metastasis.
[34] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[35] Ming Yi,et al. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data , 2006, BMC Bioinformatics.
[36] P. Khatri,et al. A systems biology approach for pathway level analysis. , 2007, Genome research.
[37] Ben Fabry,et al. Contractile forces in tumor cell migration. , 2008, European journal of cell biology.
[38] Klaus Pantel,et al. Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.
[39] A. Koong,et al. The RGD Domain of Human Osteopontin Promotes Tumor Growth and Metastasis through Activation of Survival Pathways , 2010, PloS one.
[40] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[41] Michael Lappe,et al. From gene networks to gene function. , 2003, Genome research.
[42] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[43] G. Fontanini,et al. Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[44] P. Johnston,et al. Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation , 2008, Molecular Cancer Therapeutics.